| English Name | Research Code | Highest Development Stage | Company | Indication | Clinical Trial |
|---|---|---|---|---|---|
| Ofranergene obadenovec | VB-111; GT-111 | Phase 3 Clinical | Vascular Pharmaceuticals Inc | Ovarian Neoplasms; Thyroid Carcinoma, Anaplastic; Neoplasms; Glioblastoma; Neuroendocrine Tumors; Colorectal Neoplasms | Details |
| Atrosab | Phase 1 Clinical | Celonic | Inflammation | Details |




